Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR-mediated VEGF production. [electronic resource]
Producer: 20170426Description: 1414-1426 p. digitalISSN:- 1098-2744
- Animals
- Antineoplastic Agents -- pharmacology
- Breast Neoplasms -- blood supply
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- ErbB Receptors -- genetics
- Female
- Human Umbilical Vein Endothelial Cells -- drug effects
- Humans
- Mice, Nude
- Neovascularization, Pathologic -- drug therapy
- Sesquiterpenes -- pharmacology
- Vascular Endothelial Growth Factor A -- metabolism
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.